相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MMP-9 (Gelatinase B) Expression is Associated With Disease-Free Survival and Disease-Specific Survival in Colorectal Cancer Patients
Riyad Bendardaf et al.
CANCER INVESTIGATION (2010)
Updated Biological Roles for Matrix Metalloproteinases and New Intracellular Substrates Revealed by Degradomics
Georgina S. Butler et al.
BIOCHEMISTRY (2009)
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature
Andrea Koehrmann et al.
BMC CANCER (2009)
Mapping proteolytic cancer cell-extracellular matrix interfaces
Katarina Wolf et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers
Natalie Jeffery et al.
HISTOPATHOLOGY (2009)
Polymorphisms in tissue inhibitors of metalloproteinases-2 and-3 and breast cancer susceptibility and survival
Neeraja B. Peterson et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Epigenetic Control of the Invasion-promoting MT1-MMP/MMP-2/TIMP-2 Axis in Cancer Cells
Andrei V. Chernov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Matrix Metalloproteinases As Novel Biomarkers and Potential Therapeutic Targets in Human Cancer
Roopali Roy et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not
A. M. J. Langers et al.
BRITISH JOURNAL OF CANCER (2008)
Tissue inhibitor of metalloproteinase-2 G-418C polymorphism is associated with an increased risk of gastric cancer in a Chinese population
L. Yang et al.
EJSO (2008)
The regulation of matrix metalloproteinases and their inhibitors
Ian A. Clark et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma
Toshimichi Asano et al.
JOURNAL OF SURGICAL RESEARCH (2008)
Tissue Inhibitors of Metalloproteinases in Cell Signaling: Metalloproteinase-Independent Biological Activities
William G. Stetler-Stevenson
SCIENCE SIGNALING (2008)
Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer
J. Decock et al.
CLINICAL GENETICS (2008)
Association of matrix metalloproteinase-2 and-9 promoter polymorphisms with colorectal cancer in Chinese
Enping Xu et al.
MOLECULAR CARCINOGENESIS (2007)
Matrix metalloproteinase-9-1562C>T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer
Li-Li Xing et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Prognostic significance of matrix metalloproteinases-1,-2,-7 and-13 and tissue inhibitors of metalloproteinases-1,-2,-3 and-4 in colorectal cancer
Marja Hilska et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Clinical implications of matrix metalloproteinase-1,-3,-7,-9,-12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer
Mijung Woo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer
Chun-Ying Wu et al.
EUROPEAN JOURNAL OF CANCER (2007)
Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population
Sue Wilson et al.
BMC CANCER (2006)
Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer
Michel F. P. van der Jagt et al.
CANCER LETTERS (2006)
MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases
Martin Illemann et al.
MOLECULAR CANCER RESEARCH (2006)
Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer
FJGM Kubben et al.
BRITISH JOURNAL OF CANCER (2006)
Prognostic value of E-cadherin, beta-catenin, MMPs (7 and 9), and TIMPs (1 and 2) in patients with colorectal carcinoma
F Roca et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in colorectal carcinoma invasion and metastasis
Bing-Hui Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
TIMP-2: an endogenous inhibitor of angiogenesis
WG Stetler-Stevenson et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes
YF Zhou et al.
CARCINOGENESIS (2004)
Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype
F Grieu et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Role of matrix metalloproteinases (MMPs) in colorectal cancer
S Zucker et al.
CANCER AND METASTASIS REVIEWS (2004)
Matrix metalloproteinases in colorectal cancer: Is it worth talking about?
RA Wagenaar-Miller et al.
CANCER AND METASTASIS REVIEWS (2004)
Matrix metalloproteinases and tissue inhibitors of metalloproteinases - Structure, function, and biochemistry
R Visse et al.
CIRCULATION RESEARCH (2003)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
HM Collins et al.
BRITISH JOURNAL OF CANCER (2001)
分享论文
